SCHEMBL295227

SCHEMBL295227

CC1CCC(O)C(C(C)(C)C)C1

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 2/20 0.40
TRPM8 Q7Z2W7 2/20 0.40
GBA1 P04062 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3293913 0.81 TRPA1 (0.45) TRPA1TRPM8GBA1
SCHEMBL18833331 0.81 TRPA1 (0.45) TRPA1TRPM8GBA1
SCHEMBL20903636 0.81 TRPA1 (0.45) TRPA1TRPM8GBA1
SCHEMBL3418318 0.81 TRPA1 (0.45) TRPA1TRPM8GBA1
SCHEMBL25248419 0.78 SLC18A3 (0.33) GBA1
SCHEMBL18717686 0.76
SCHEMBL5699349 0.76 SLC18A3 (0.41) GBA1
SCHEMBL12649859 0.76
SCHEMBL517032 0.74 SLC18A3 (0.34)
SCHEMBL3104581 0.74 GBA1 (0.30) GBA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 369 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4711010-A2 PRO-PERFUME COMPOSITIONS Firmenich SA (CH) 2026-03-18 EP claimed
US-12509482-B2 3′-ketoglycoside compound for the slow release of a volatile alcohol GLYCOSCIENCE, S.L. (ES) 2025-12-30 US claimed
CN-115427421-B 3' -Ketoglycoside compounds for slow release of volatile alcohols 格莱克科学有限公司 2025-04-01 CN claimed
US-20230183284-A1 3'-KETOGLYCOSIDE COMPOUND FOR THE SLOW RELEASE OF A VOLATILE ALCOHOL GLYCOSCIENCE, S.L. (ES) 2023-06-15 US claimed
EP-4103576-A1 3'-KETOGLYCOSIDE COMPOUND FOR THE SLOW RELEASE OF A VOLATILE ALCOHOL Glycoscience, S.L. (ES) 2022-12-21 EP claimed
WO-2021160670-A1 3'-KETOGLYCOSIDE COMPOUND FOR THE SLOW RELEASE OF A VOLATILE ALCOHOL GLYCOSCIENCE, S.L. (ES) 2021-08-19 WO claimed
US-10590365-B2 Compounds for a controlled release of active molecules FIRMENICH SA (CH) 2020-03-17 US claimed
EP-3011000-B1 COMPOUNDS FOR A CONTROLLED RELEASE OF ACTIVE MOLECULES FIRMENICH & CIE (CH) 2017-08-09 EP claimed
US-20170088793-A1 COMPOUNDS FOR A CONTROLLED RELEASE OF ACTIVE MOLECULES FIRMENICH SA (CH) 2017-03-30 US claimed
US-9550960-B2 Compounds for a controlled release of active molecules FIRMENICH SA (CH) 2017-01-24 US claimed
EP-0953562-A1 Beta, gamma-unsaturated delta-keto esters Givaudan Roure (International) S.A. (CH) 1999-11-03 EP claimed
WO-1999044575-A1 FRAGRANCE ENHANCING COMPOSITIONS FOR COSMETIC PRODUCTS COLGATE-PALMOLIVE COMPANY (US) 1999-09-10 WO claimed
WO-1998058899-A1 FRAGRANCE PRECURSOR COMPOUNDS GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) 1998-12-30 WO claimed
EP-0878497-A2 Fragrance precursor compounds GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) 1998-11-18 EP claimed
EP-0258787-B1 USE OF 2-TERT.-BUTYL-4-METHYL-CYCLOHEXANOL AS A PERFUMING AGENT AS WELL AS A CONSTITUENT OF PERFUMING COMPOSITIONS BASF Aktiengesellschaft (DE) 1992-03-04 EP claimed
EP-0262388-B1 DERIVATIVES OF 2-TERT.-BUTYL-4-METHYL-CYCLOHEXANOL, THEIR PREPARATION AND USE AS FRAGRANCE COMPOUNDS BASF Aktiengesellschaft (DE) 1992-03-04 EP claimed
US-4757051-A 2-tert-butyl-4-methylcyclohexanol derivatives, their preparation and their use as scents BASF AKTIENGESELLSCHAFT (DE) 1988-07-12 US claimed
US-4751214-A INTENSIFIER, STABILITY; COSMETICS, CLEANERS BASF AKTIENGESELLSCHAFT (DE) 1988-06-14 US claimed
EP-0262388-A2 Derivatives of 2-tert.-butyl-4-methyl-cyclohexanol, their preparation and use as fragrance compounds BASF Aktiengesellschaft (DE) 1988-04-06 EP claimed
EP-0258787-A2 Use of 2-tert.-butyl-4-methyl-cyclohexanol as a perfuming agent as well as a constituent of perfuming compositions BASF Aktiengesellschaft (DE) 1988-03-09 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183284-A1 3'-KETOGLYCOSIDE COMPOUND FOR THE SLOW RELEASE OF A VOLATILE ALCOHOL ADH1C, UGCG, ST6GAL1 TRPA1 1683/4885TRPM8 2065/4885GBA1 647/4885
US-10590365-B2 Compounds for a controlled release of active molecules UGT1A3, GUSB, UGT1A4 TRPA1 1089/4885TRPM8 1954/4885GBA1 1495/4885
US-12509482-B2 3′-ketoglycoside compound for the slow release of a volatile alcohol EBP, MGAT1, MGAT3 TRPA1 1897/4885TRPM8 1211/4885GBA1 1613/4885
US-20170088793-A1 COMPOUNDS FOR A CONTROLLED RELEASE OF ACTIVE MOLECULES UGT1A3, GUSB, UGT1A4 TRPA1 1089/4885TRPM8 1954/4885GBA1 1495/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.